Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Friday, October 23, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Venture Capital
Venture Capital
Venture Capital
Estuary Biotherapeutics Launches with $103 Million to Advance Gene Therapies for Kidney Disease
Life Sciences Times
-
October 16, 2026
Venture Capital
Acta Pharmaceuticals Raises $24 Million to Advance Alzheimer’s Disease Treatments
Life Sciences Times
-
October 15, 2026
Venture Capital
Soufflé Therapeutics Raises $135 Million in Series B Financing to Advance RNA Therapies
Life Sciences Times
-
October 13, 2026
Venture Capital
Consano Bio Raises More Than $15 Million to Advance Chronic Sciatica Therapy
Life Sciences Times
-
October 5, 2026
Venture Capital
ai3Bio Launches With $48 Million Series A to Advance Autoimmune Disease Therapies
Life Sciences Times
-
September 29, 2026
Venture Capital
Vyome Subsidiary LiveChain Moves to Acquire Senior Secured Note in MIT-Backed Humanyze
Life Sciences Times
-
December 22, 2025
0
Venture Capital
Manifold Raises $18 Million Series B to Expand Vertical AI Platform for Life Sciences
Life Sciences Times
-
December 19, 2025
0
Venture Capital
Orum Therapeutics Raises Approximately $100 Million to Advance Degrader Antibody Conjugate Programs
Life Sciences Times
-
December 19, 2025
0
Venture Capital
Syremis Therapeutics Launches With $165 Million Series A to Advance New Treatments for Mental Health Disorders
Life Sciences Times
-
December 19, 2025
0
Venture Capital
Neurable Raises $35 Million Series A to Expand Everyday Brain-Computer Interface Technology
Life Sciences Times
-
December 19, 2025
0
Venture Capital
Cosette Pharmaceuticals Terminates Agreement to Acquire Mayne Pharma
Life Sciences Times
-
December 12, 2025
0
Venture Capital
Kymera Therapeutics Closes Upsized $602 Million Public Offering, Underwriters Fully Exercise Option
Life Sciences Times
-
December 12, 2025
0
Biotech
Allonnia raises more than $20 million to accelerate deployment of materials biotechnology
Life Sciences Times
-
December 10, 2025
0
Venture Capital
EpilepsyGTx raises $33 million Series A to advance single-dose gene therapy for focal refractory epilepsy
Life Sciences Times
-
December 10, 2025
0
Venture Capital
Montagu and Kohlberg Agree to Acquire Teleflex Medical OEM for $1.5 Billion
Life Sciences Times
-
December 9, 2025
0
Venture Capital
Mirum Pharmaceuticals to Acquire Bluejay Therapeutics, Expanding Rare Disease Portfolio
Life Sciences Times
-
December 8, 2025
0
Medtech
Aptyx Expands With New Precision Extrusion Center of Excellence in Boston Medtech Corridor
Life Sciences Times
-
December 5, 2025
0
1
...
5
6
7
...
115
Page 6 of 115
Most Read
Alnylam Reports Promising Phase 1b Results for Experimental Huntington’s Disease Treatment
October 23, 2026
Zai Lab Reports Promising Early Results for Experimental Small Cell Lung Cancer Treatment
October 23, 2026
Takeda Reports Improved Survival in Phase 3 Trial of Experimental Gastric Cancer Treatment
October 23, 2026
Convergent Therapeutics Reports Promising Phase 2 Results for Prostate Cancer Treatment
October 23, 2026